Chicago Teen Develops Vaccine That May Fight Colon Cancer

Sup Travellers?! 19-year-old Kevin Stonewall has dedicated a whole lot of his time in his quest of curing colon cancer and every second that he spends in the lab brings him closer and closer to actually completing his quest.

The Chicago teen, who works at a Rush University lab in Ashburn, discovered a critical age-related drawback in an experimental vaccine to prevent colon cancer in mice.

Stonewall set out to test whether the potential colon cancer vaccine had the same effect on both younger and older mice. He found that after three days of living with the vaccine, all of the younger mice’s tumors were eliminated and they showed immunity to colon cancer.

None of the older mice, however, were responsive to the vaccine leading to tumor growth.

It's an assumption that if the vaccine works on mice it can definitely work on humans but the research is still ongoing as Stonewall continues his studies at the University of Wisconsin.

“I am very passionate about doing colon cancer research,” Stonewall said. “If it works on humans, I would be overwhelmed. My whole life would flash in front of me.”

Stonewall’s research findings were presented at the national meeting for the Society for ImmunoTherapy of Cancer in Washington, D.C., and he is listed as lead author.

The vaccine does have it's drawbacks since so far it only worked on younger mice. It's not very common for young people to have colon cancer and more than two-thirds of colon cancer patients are elderly. But I'm sure that with continual effort he can accomplish the daunting tasks of not only curing colon cancer but cancer in general. Anyway, my name is Trinikid and you've just been informed.